Minerva Neurosciences, Inc. — Director's Dealing 2020

Oct 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2020-10-13

Reporting Person: Davidson Michael (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-13	Employee Stock Option (right to buy)	$3.50	A	85000	Acquired	2030-10-12	Common Stock (85000)	Direct

Footnotes

F1: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022.